ATE71620T1 - N-substituierte 3,4-dihydropyrimidinverbindungen als mittel zur behandlung von erkrankungen des kardiovaskularen systems. - Google Patents

N-substituierte 3,4-dihydropyrimidinverbindungen als mittel zur behandlung von erkrankungen des kardiovaskularen systems.

Info

Publication number
ATE71620T1
ATE71620T1 AT88102557T AT88102557T ATE71620T1 AT E71620 T1 ATE71620 T1 AT E71620T1 AT 88102557 T AT88102557 T AT 88102557T AT 88102557 T AT88102557 T AT 88102557T AT E71620 T1 ATE71620 T1 AT E71620T1
Authority
AT
Austria
Prior art keywords
agents
substituted
cardiovascular system
carbon atoms
diseases
Prior art date
Application number
AT88102557T
Other languages
English (en)
Inventor
Hidetsura Cho
Masaru Ueda
Original Assignee
Suntory Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Suntory Ltd filed Critical Suntory Ltd
Application granted granted Critical
Publication of ATE71620T1 publication Critical patent/ATE71620T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/20—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • General Health & Medical Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT88102557T 1987-02-21 1988-02-22 N-substituierte 3,4-dihydropyrimidinverbindungen als mittel zur behandlung von erkrankungen des kardiovaskularen systems. ATE71620T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP62038345A JPS63208580A (ja) 1987-02-21 1987-02-21 Ｎ置換３，４−ジヒドロピリミジン誘導体および循環器系疾患治療剤
EP88102557A EP0280227B1 (de) 1987-02-21 1988-02-22 N-Substituierte 3,4-Dihydropyrimidinverbindungen als Mittel zur Behandlung von Erkrankungen des kardiovaskularen Systems

Publications (1)

Publication Number Publication Date
ATE71620T1 true ATE71620T1 (de) 1992-02-15

Family

ID=12522695

Family Applications (1)

Application Number Title Priority Date Filing Date
AT88102557T ATE71620T1 (de) 1987-02-21 1988-02-22 N-substituierte 3,4-dihydropyrimidinverbindungen als mittel zur behandlung von erkrankungen des kardiovaskularen systems.

Country Status (6)

Country Link
US (1) US4920124A (de)
EP (1) EP0280227B1 (de)
JP (1) JPS63208580A (de)
AT (1) ATE71620T1 (de)
DE (1) DE3867652D1 (de)
ES (1) ES2039485T3 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6268369B1 (en) 1994-11-16 2001-07-31 Synaptic Pharmaceutical Corporation 5-(heterocyclic alkyl)-6-aryl-dihydropyrimidines
EE9700209A (et) 1994-11-16 1998-04-15 Synaptic Pharmaceutical Corporation Dihüdropürimidiinid ja nende kasutamine
US6228861B1 (en) 1995-11-16 2001-05-08 Synaptic Pharmaceutical Corporation Dihydropyrimidines and uses thereof
US6172066B1 (en) 1996-05-16 2001-01-09 Synaptic Pharmaceutical Corporation Dihydropyrimidines and uses thereof
US6245773B1 (en) 1996-05-16 2001-06-12 Synaptic Pharmaceutical Corporation 5-(heterocyclic alkyl)-6-aryl-dihydropyrimidines
US6274585B1 (en) 1998-12-23 2001-08-14 Synaptic Pharmaceutical Corporation Dihydropyrimidines and uses thereof
US6680323B2 (en) 1998-12-23 2004-01-20 Synaptic Pharmaceutical Corporation Dihydropyrimidines and uses thereof
US6720324B2 (en) 2000-07-05 2004-04-13 Synaptic Pharmaceutical Corporation Selective melanin concentrating hormone-1 (MCH1) receptor antagonists and uses thereof
WO2005007124A2 (en) 2003-07-23 2005-01-27 Bristol-Myers Squibb Company Substituted dihydropyrimidine inhibitors of calcium channel function

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3234684A1 (de) * 1982-09-18 1984-03-22 Bayer Ag, 5090 Leverkusen Neue dihydropyrimidine, verfahren zu ihrer herstellung sowie ihre verwendung in arzneimitteln
JPS60214778A (ja) * 1984-03-08 1985-10-28 Suntory Ltd Ν置換３，４−ジヒドロピリミジン誘導体ならびにその製造法および用途
US4683234A (en) * 1984-05-19 1987-07-28 Suntory Limited 2,6-Dimethyl-3N,5-disubstituted-4-(substituted phenyl)3,4-dihydropyrimidine compounds and a method for treating disorders of cardiocircular system
US4772602A (en) * 1985-03-15 1988-09-20 Suntory Limited N-substituted 3,4-dihydropyrimidine derivatives as agents for treating disorders of cardiovascular system

Also Published As

Publication number Publication date
ES2039485T3 (es) 1993-10-01
JPS63208580A (ja) 1988-08-30
EP0280227A1 (de) 1988-08-31
US4920124A (en) 1990-04-24
DE3867652D1 (de) 1992-02-27
EP0280227B1 (de) 1992-01-15

Similar Documents

Publication Publication Date Title
ATE165097T1 (de) Anwendung von indolocarbazol-derivaten zur behandlung von prostataerkrankungen
DE69328474D1 (de) Verwendung von substituierten Adeninderivaten zur Behandlung von MultipleSklerose
ATE86247T1 (de) 3-indolpyruvsaeure-derivate und deren verwendung als arznemittel.
FI935529A0 (fi) Aminometylensubstituerade icke-aromatiska heterocykliska foereningar
ES2164072T3 (es) Heterociclos no aromaticos que contienen nitrogeno sustituidos con bencilamino.
FI931370A (fi) Kvaeve innehaollande analoger av icke-aromatiska heterocykliska foereningar med en fusionerad ring
DE60037892D1 (de) Nitroimidazolpräparationen zur äusseren anwendung zur behandlung von atopischer dermatitis
ATE103812T1 (de) Zusammensetzung zur behandlung von ischaemischen stoerungen in organen.
ATE63906T1 (de) 3,5-disubstituierte 4,5-dihydroisoxazole als transglutaminasehemmer.
ATE112762T1 (de) Herstellung und verwendung von n-jodopropargyl- oxycarbonylaminosäure-estern als antimicrobielle mittel.
FI935777A0 (fi) Inhibitorer foer HIV-proteas anvaendbara vid behandling av AIDS
ATE71620T1 (de) N-substituierte 3,4-dihydropyrimidinverbindungen als mittel zur behandlung von erkrankungen des kardiovaskularen systems.
DE69833797D1 (de) Substituierte 2-benzylamino-2-phenyl-acetamidverbindungen
ATE180669T1 (de) Verwendung von pregnanderivaten zur behandlung von tumoren
ES2038668T3 (es) Vasodilatadores de benzotiazepina dotados de sustitucion aralquilica.
ATE150751T1 (de) Neuroprotektive 3,4-dihydro-2(1h)-chinolone
DE68900516D1 (de) Therapeutische mittel zur behandlung von magengeschwueren.
ATE135211T1 (de) 5-aryl-4-alkyl-3h-1,2,4-triazol-3-thione zur verbesserung des gedächtnisses
NO152370C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 1,8-dihydroksy-9-(1oh) antracenon-derivater
DE3779813D1 (en) 1,4-dihydropyridinderivate.
DK601583A (da) Carbamyloxybenzhydrolderivater
ATE283269T1 (de) 5-(heteroaryl)alkyl)-3-oxo-pyrido(1,2- a)benzimidazol-4-carboxamid (pbi) derivate zur behandlung von störungen des zentralen nervensystems
DE69823650D1 (de) Azasteroidverbindung zur behandlung oder vorbeugung von prostatakrebs
ATE132038T1 (de) Verbindung zur behandlung von störungen des neurotransmittersystems im gehirn
ATE264840T1 (de) Azetidincarboxamid-derivate zur behandlung von zns störungen

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee